-
Information-Publications
-
Construction of an ATP-Activated Y-Shape DNA Probe for Smart miRNA Imaging in Living CellsDetails -
Oncogenic EFNA4 amplification promotes lung adenocarcinoma lymph node metastasisDetails -
Construction and functional verification of size-reduced plasmids based on TMP resistance gene dfrB10Details -
Cytotoxic CD161− CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosusDetails -
LGR5-positive fibroblasts orchestrate skin mechanoadaptation through JAK1 modulationDetails -
SUMOylation of the ubiquitin ligase component KEAP1 at K39 upregulates NRF2 and its target function in lung cancer cell proliferationDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
